Your browser doesn't support javascript.
loading
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases.
Hazlewood, Glen S; Colmegna, Ines; Hitchon, Carol; Fortin, Paul R; Bernatsky, Sasha; Clarke, Ann E; Mosher, Dianne; Wilson, Todd; Thomas, Megan; Barber, Claire E H; Harrison, Mark; Bansback, Nick; Proulx, Laurie; Richards, Dawn P; Kaplan, Gilaad G.
Afiliación
  • Hazlewood GS; G.S. Hazlewood, MD, PhD, A.E. Clarke, MD, D. Mosher, MD, C.E.H. Barber, MD, PhD, Department of Medicine, and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia; gshazlew@ucalgary.ca.
  • Colmegna I; I. Colmegna, MD, S. Bernatsky, MD, PhD, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec.
  • Hitchon C; C. Hitchon, MD, MSc, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba.
  • Fortin PR; P.R. Fortin, MD, Division de Rhumatologie, Departement de Medecine, CHU de Quebec, and Centre de Recherche ARThrite, Universite Laval, Quebec City, Quebec.
  • Bernatsky S; I. Colmegna, MD, S. Bernatsky, MD, PhD, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec.
  • Clarke AE; G.S. Hazlewood, MD, PhD, A.E. Clarke, MD, D. Mosher, MD, C.E.H. Barber, MD, PhD, Department of Medicine, and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia.
  • Mosher D; G.S. Hazlewood, MD, PhD, A.E. Clarke, MD, D. Mosher, MD, C.E.H. Barber, MD, PhD, Department of Medicine, and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia.
  • Wilson T; T. Wilson, PhD, Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary.
  • Thomas M; M. Thomas, MSc, Arthritis Research Canada, and Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia.
  • Barber CEH; G.S. Hazlewood, MD, PhD, A.E. Clarke, MD, D. Mosher, MD, C.E.H. Barber, MD, PhD, Department of Medicine, and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, and Arthritis Research Canada, Vancouver, British Columbia.
  • Harrison M; M. Harrison, PhD, Arthritis Research Canada, and Pharmaceutical Sciences, and School of Population and Public Health, University of British Columbia, and Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia.
  • Bansback N; N. Bansback, PhD, Arthritis Research Canada, and School of Population and Public Health, University of British Columbia, and Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia.
  • Proulx L; L. Proulx, BCom, D.P. Richards, PhD, Canadian Arthritis Patient Alliance, Ontario.
  • Richards DP; L. Proulx, BCom, D.P. Richards, PhD, Canadian Arthritis Patient Alliance, Ontario.
  • Kaplan GG; G.G. Kaplan, MD, MPH, Department of Medicine, and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
J Rheumatol ; 50(7): 949-957, 2023 07.
Article en En | MEDLINE | ID: mdl-36642432

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Idioma: En Revista: J Rheumatol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Idioma: En Revista: J Rheumatol Año: 2023 Tipo del documento: Article